Abingdon Health Plc
ABDXF · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 3.9% | 209.1% | -58.9% | – |
| Gross Profit | $0 | $0 | -$0 | $0 |
| % Margin | 30.6% | 64.5% | -17.6% | 49.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -50.7% | -0% | -37.1% | -6.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -81.5% | -1.8% | -100% | -35.1% |
| EPS Diluted | -0.007 | -0 | -0.002 | -0.003 |
| % Growth | -3,450% | 90% | 41.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |